|
US6602864B1
(en)
*
|
1996-12-13 |
2003-08-05 |
Aventis Pharma Deutschland Gmbh |
Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
|
|
WO1999011658A1
(en)
*
|
1997-08-29 |
1999-03-11 |
Proteus Molecular Design Ltd. |
Meta-benzamidine derivatives as serin protease inhibitors
|
|
KR20010042042A
(ko)
|
1998-03-19 |
2001-05-25 |
에가시라 구니오 |
아미노이소퀴놀린 유도체
|
|
US6747023B1
(en)
*
|
1998-08-11 |
2004-06-08 |
Daiichi Pharmaceutical Co., Ltd. |
Sulfonyl derivatives
|
|
EP0997474B1
(en)
*
|
1998-08-14 |
2003-10-29 |
Pfizer Inc. |
Antithrombotic agents
|
|
TW575567B
(en)
|
1998-10-23 |
2004-02-11 |
Akzo Nobel Nv |
Serine protease inhibitor
|
|
WO2000038683A1
(en)
*
|
1998-12-23 |
2000-07-06 |
Du Pont Pharmaceuticals Company |
THROMBIN OR FACTOR Xa INHIBITORS
|
|
KR20000047461A
(ko)
*
|
1998-12-29 |
2000-07-25 |
성재갑 |
트롬빈 억제제
|
|
US6716838B1
(en)
|
1999-05-19 |
2004-04-06 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
|
|
US7015230B1
(en)
|
1999-05-19 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
|
|
US6867217B1
(en)
|
1999-05-19 |
2005-03-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
|
|
CA2373509A1
(en)
*
|
1999-05-19 |
2000-11-23 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
|
|
US6664255B1
(en)
|
1999-05-19 |
2003-12-16 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
|
|
US6750342B1
(en)
|
1999-05-19 |
2004-06-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
US6653316B1
(en)
|
1999-05-19 |
2003-11-25 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
US6458952B1
(en)
|
1999-05-19 |
2002-10-01 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
|
|
JP2003500382A
(ja)
*
|
1999-05-24 |
2003-01-07 |
シーオーアール セラピューティクス インコーポレイテッド |
Ｘａ因子の阻害剤
|
|
DE60022508T2
(de)
*
|
1999-06-14 |
2006-06-08 |
Eli Lilly And Co., Indianapolis |
Inhibitoren von serin proteasen
|
|
GB9929552D0
(en)
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
EP1192135A2
(en)
*
|
1999-06-14 |
2002-04-03 |
Eli Lilly And Company |
Serine protease inhibitors
|
|
US6583179B2
(en)
*
|
1999-12-27 |
2003-06-24 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
|
|
WO2001068605A1
(en)
|
2000-03-13 |
2001-09-20 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
|
|
CA2403558A1
(en)
*
|
2000-03-23 |
2001-09-27 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
ATE289299T1
(de)
|
2000-04-05 |
2005-03-15 |
Pharmacia Corp |
Polyzyclisch aryl und heteroaryl substituierte 4- pyronen verwendbar als selektive hemmung von dem koagulationsprozess
|
|
EP1268428A2
(en)
|
2000-04-05 |
2003-01-02 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
|
|
JP2004501077A
(ja)
|
2000-04-17 |
2004-01-15 |
ファルマシア・コーポレーション |
凝固カスケードの選択的阻害に有用な多環式アリールおよびヘテロアリール置換１，４−キノン
|
|
SI20582A
(sl)
*
|
2000-05-05 |
2001-12-31 |
Univerza V Ljubljani |
Novi inhibitorji trombina, njihova priprava in uporaba
|
|
US7229986B2
(en)
|
2000-05-16 |
2007-06-12 |
Takeda Pharmaceutical Company Ltd. |
Melanin-concentrating hormone antagonist
|
|
AU2001222501A1
(en)
*
|
2000-05-18 |
2001-11-26 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
|
GB0030305D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
GB0030304D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
GB0030303D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
GB0030306D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
|
US7074934B2
(en)
|
2000-06-13 |
2006-07-11 |
Tularik Limited |
Serine protease inhibitors
|
|
CN1441784A
(zh)
*
|
2000-07-12 |
2003-09-10 |
阿克佐诺贝尔公司 |
含有氨基异喹啉基团的凝血酶抑制剂
|
|
US6906192B2
(en)
|
2000-11-07 |
2005-06-14 |
Bristol Myers Squibb Company |
Processes for the preparation of acid derivatives useful as serine protease inhibitors
|
|
US6642252B2
(en)
|
2000-11-07 |
2003-11-04 |
Bristol-Myers Squibb Company |
Acid derivatives useful as serine protease inhibitors
|
|
US7119094B1
(en)
|
2000-11-20 |
2006-10-10 |
Warner-Lambert Company |
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
|
|
EP1351686A2
(en)
|
2000-11-20 |
2003-10-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
|
|
US7015223B1
(en)
|
2000-11-20 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
|
|
GB0114185D0
(en)
|
2001-06-12 |
2001-08-01 |
Protherics Molecular Design Lt |
Compounds
|
|
HUP0304058A2
(hu)
|
2001-01-30 |
2004-04-28 |
Bristol-Myers Squibb Company |
Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
|
|
GB0114004D0
(en)
|
2001-06-08 |
2001-08-01 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0114005D0
(en)
|
2001-06-08 |
2001-08-01 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP1288713A1
(en)
*
|
2001-08-29 |
2003-03-05 |
Chugai Photo Chemical Co. Ltd. |
Processing agent for silver halide color photosensitive material and processing method thereof
|
|
MXPA04003163A
(es)
|
2001-10-03 |
2004-07-08 |
Pharmacia Corp |
Compuestos heterociclicos de 6 elementos utiles para inhibicion selectiva de la casdada de coagulacion.
|
|
WO2003093242A2
(en)
|
2001-10-03 |
2003-11-13 |
Pharmacia Corporation |
Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
|
|
EP1594505A4
(en)
*
|
2003-02-11 |
2008-08-13 |
Bristol Myers Squibb Co |
PHENYLGLYCIN DERIVATIVES USEFUL AS SERINE PROTEASE INHIBITORS
|
|
WO2004072102A2
(en)
*
|
2003-02-11 |
2004-08-26 |
Bristol-Myers Squibb Company |
Benzene acetamide compounds useful as serine protease inhibitors
|
|
EP1644347A1
(en)
*
|
2003-06-20 |
2006-04-12 |
Arena Pharmaceuticals, Inc. |
N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT sb 2C /sb RECEPTOR ASSOCIATED DISEASES
|
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
|
CA2594987A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Shionogi & Co., Ltd. |
Therapeutic agent for constipation
|
|
JP5065908B2
(ja)
|
2004-12-24 |
2012-11-07 |
プロシディオン・リミテッド |
Ｇタンパク質結合受容体作動薬
|
|
PE20061117A1
(es)
*
|
2005-01-10 |
2006-10-13 |
Bristol Myers Squibb Co |
DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
WO2007002313A2
(en)
*
|
2005-06-24 |
2007-01-04 |
Bristol-Myers Squibb Company |
Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
|
|
TWI389899B
(zh)
*
|
2006-08-08 |
2013-03-21 |
Msd Oss Bv |
具口服活性之凝血酶抑制劑
|
|
AR063258A1
(es)
*
|
2006-10-13 |
2009-01-14 |
Actelion Pharmaceuticals Ltd |
Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos.
|
|
WO2008108445A1
(ja)
|
2007-03-07 |
2008-09-12 |
Takeda Pharmaceutical Company Limited |
ベンゾオキサゼピン誘導体およびその用途
|
|
WO2008144483A2
(en)
*
|
2007-05-18 |
2008-11-27 |
Armgo Pharma, Inc. |
Agents for treating disorders involving modulation of ryanodine receptors
|
|
EP2138494A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted alkyl pyrimidin-4-one derivatives
|
|
EP2138492A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted pyrimidin-4-one derivatives
|
|
EP2138495A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
|
|
EP2138485A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted N-Oxide pyrazine derivatives
|
|
EP2138493A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted pyrimidone derivatives
|
|
EP2138488A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
|
|
EP2138498A1
(en)
|
2008-06-26 |
2009-12-30 |
sanofi-aventis |
Substituted tricyclic derivatives against neurodegenerative diseases
|
|
CN101684077B
(zh)
|
2008-09-24 |
2013-01-02 |
浙江九洲药业股份有限公司 |
N-酰基联苯丙氨酸的制备方法
|
|
CN101774941A
(zh)
|
2009-01-13 |
2010-07-14 |
浙江九洲药业股份有限公司 |
2-酰基氨基-3-联苯基丙酸的制备及拆分方法
|
|
CN101555211B
(zh)
*
|
2009-05-13 |
2012-01-25 |
浙江九洲药业股份有限公司 |
2-酰基氨基-3-联苯基丙酸的化学合成方法
|
|
RU2534619C2
(ru)
*
|
2009-09-23 |
2014-11-27 |
Чжэцзян Цзючжоу Фармасьютикл Ко., Лтд. |
Способ получения n-ацилбифенилаланина
|
|
WO2012015949A2
(en)
*
|
2010-07-29 |
2012-02-02 |
Joule Unlimited Technologies, Inc. |
Methods and compositions for improving yields of reduced products of photosynthetic microorganisms
|
|
DE202011110963U1
(de)
|
2010-11-05 |
2017-11-07 |
Senomyx, Inc. |
Verbindungen, die als Modulatoren von TRPM8 nützlich sind
|
|
EP2606893A1
(en)
*
|
2011-12-21 |
2013-06-26 |
Sanofi |
Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
|
|
MY174018A
(en)
|
2013-05-23 |
2020-03-04 |
Kalvista Pharmaceuticals Ltd |
Heterocyclic derivates
|
|
ITUB20150417A1
(it)
*
|
2015-05-08 |
2016-11-08 |
Dipharma Francis Srl |
Procedimento per la preparazione di composti piperidinici
|
|
MX389514B
(es)
|
2015-10-01 |
2025-03-20 |
Firmenich Incorporated |
Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
|
|
GB201805174D0
(en)
*
|
2018-03-29 |
2018-05-16 |
Univ Leeds Innovations Ltd |
Compounds
|
|
GB201807014D0
(en)
*
|
2018-04-30 |
2018-06-13 |
Univ Leeds Innovations Ltd |
Factor xlla inhibitors
|
|
AU2020300002A1
(en)
|
2019-07-01 |
2022-02-24 |
Tonix Pharma Limited |
Anti-CD154 antibodies and uses thereof
|
|
WO2021032935A1
(en)
*
|
2019-08-21 |
2021-02-25 |
Kalvista Pharmaceuticals Limited |
Enzyme inhibitors
|
|
WO2021032933A1
(en)
*
|
2019-08-21 |
2021-02-25 |
Kalvista Pharmaceuticals Limited |
Enzyme inhibitors
|
|
AR121715A1
(es)
*
|
2020-04-03 |
2022-06-29 |
Biocryst Pharm Inc |
Pirrolopirimidinaminas como inhibidores del sistema del complemento
|
|
US20240059781A1
(en)
|
2021-01-06 |
2024-02-22 |
Tonix Pharma Limited |
Methods of inducing immune tolerance with modified anti-cd154 antibodies
|
|
US20260062443A1
(en)
*
|
2022-08-23 |
2026-03-05 |
Alexion Pharmaceuticals, Inc. |
Pharmaceutical compounds for the treatment of complement mediated disorders
|
|
WO2025248134A1
(en)
|
2024-05-31 |
2025-12-04 |
Tonix Pharma Limited |
Treatment methods comprising administration of modified cd154 antibodies
|
|
CN119954681B
(zh)
*
|
2025-02-05 |
2025-12-26 |
南京工业大学 |
一种小分子光交联剂、制备方法及应用
|